Purisys News

Noramco CEO Lee Karras discusses “3 Key Trends” impacting the CDMO industry
03Jun

Noramco CEO Lee Karras discusses “3 Key Trends” impacting the CDMO industry

Noramco CEO Lee Karras joined Contract Pharma for a roundtable with other thought leaders across the pharmaceutical services sector to
Noramco CEO Lee Karras discusses $25 million Halo investment with PharmTech
19Mar

Noramco CEO Lee Karras discusses $25 million Halo investment with PharmTech

Noramco, a leading global active pharmaceutical ingredients manufacturer, specializing in controlled substances, today announced its l
PURISYS ACTIVATES DRUG MASTER FILE FOR NALMEFENE, INTRODUCING NEW SOLUTION FOR ACUTE OPIOID OVERDOSE TREATMENT
10Sep

PURISYS ACTIVATES DRUG MASTER FILE FOR NALMEFENE, INTRODUCING NEW SOLUTION FOR ACUTE OPIOID OVERDOSE TREATMENT

Noramco, a leading global active pharmaceutical ingredients manufacturer, specializing in controlled substances, today announced its l
Noramco Announces Strategic Alignment with Purisys and Halo Pharma, Launching the Noramco Group as an Integrated North American-Based API and Drug Product Supply Chain Services Provider
14Mar

Noramco Announces Strategic Alignment with Purisys and Halo Pharma, Launching the Noramco Group as an Integrated North American-Based API and Drug Product Supply Chain Services Provider

Noramco, a leading global active pharmaceutical ingredients manufacturer, specializing in controlled substances, today announced its l
Noramco Announces the Acquisition of the Cambrex Drug Product Business Unit
02Nov

Noramco Announces the Acquisition of the Cambrex Drug Product Business Unit

Noramco, a leading global active pharmaceutical ingredients (API) manufacturer, specializing in controlled substances, announced today
07Jul

Purisys Adds ISO Certifications Confirming Its Commitment to Quality and Excellence

Rigorously reported, peer reviewed and immediately available without restrictions, promoting the widest readership and impact possible
Connect With Us